Key Strategic Considerations In The External Manufacture Of Active Pharmaceutical Ingredients

  • Building an external supply chain for intermediates and API
  • Developing a network of suppliers to meet the portfolio demands from development to commercial manufacture
  • Technology capabilities needs across a network (i.e. flow, high potent, etc.)
  • Assessing and mitigating process and operational risk
  • Considerations for process knowledge and regulatory filings

Leave a reply

Please enter your comment!
Please enter your name here